Key Segments:
By Animal Type
-
- Livestock Animal
- Poultry
- Swine
- Cattle
- Sheep & Goats
- Fish
- Others
- Companion Animal
- Dogs
- Cats
- Others
- Livestock Animal
By Product
-
- Antimicrobial
- Tetracyclines
- Penicillin
- Cephalosporins
- Macrolides
- Quinolones
- Others
- Antifungals
- Antivirals
- Antiparasitic
- Others
- Antimicrobial
By Route of Administration
-
- Oral
- Injectable
- Topical
- Others
By Type
-
- OTC
- Prescription
By Distribution Channel
-
- Hospital/ Clinic Pharmacy
- Retail Pharmacies
- E-commerce
Request for Segment Customization as per your Business Requirement: https://www.snsinsider.com/sample-request/7803
Regional Coverage:
North America
- US
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Poland
- Turkey
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Australia
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Request for Country Level Research Report: https://www.snsinsider.com/sample-request/7803
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g., Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the Veterinary Anti-infectives Market in 2024.
Zoetis, Boehringer Ingelheim Animal Health, Merck Animal Health, Elanco Animal Health, Bayer Animal Health, Ceva Santé Animale, Virbac, Vetoquinol S.A., Phibro Animal Health Corporation, Norbrook Laboratories, and other players.
New veterinary diagnostics and drug discovery are propelling the market growth.
The Veterinary Anti-infectives Market was USD 8.32 billion in 2024 and is expected to reach USD 13.27 billion by 2032.
The Veterinary Anti-infectives Market is expected to grow at a CAGR of 6.10% from 2025 to 2032.